Due to the limited ability of cancer cells with the IDH mutation to repair double-stranded DNA breaks in the process of homologous recombination, they become dependent on enzymes from the poly(adenosine diphosphate-ribose) polymerase (PARP) family, the activity of which allows the cancer cell to maintain the integrity of its genome. The gene discussed is IDH2; the disease is cancer.